Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06SRX
|
||||
| Former ID |
DIB016932
|
||||
| Drug Name |
MDA-19
|
||||
| Synonyms |
Cannabinoid CB2 agonist (neuropathic pain), MD Anderson Cancer Center
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Investigative | [543878] | ||
| Company |
MD Anderson Cancer Center
|
||||
| Formula |
C21H23N3O2
|
||||
| Canonical SMILES |
C\1(=N/NC(=O)c2ccccc2)/C(=O)N(c2c1cccc2)CCCCCC
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [543878] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.